Case Report: The Imperfect Association Between Craniofacial Lesion Burden and Pain in Fibrous Dysplasia

Patients with fibrous dysplasia (FD) often present with craniofacial lesions that affect the trigeminal nerve system. Debilitating pain, headache, and migraine are frequently experienced by FD patients with poor prognosis, while some individuals with similar bone lesions are asymptomatic. The clinical and biological factors that contribute to the etiopathogenesis of pain in craniofacial FD are largely unknown. We present two adult females with comparable craniofacial FD lesion size and location, as measured by 18F-sodium fluoride positron emission tomography/computed tomography (PET/CT), yet their respective pain phenotypes differed significantly. Over 4 weeks, the average pain reported by Patient A was 0.4/0–10 scale. Patient B reported average pain of 7.8/0–10 scale distributed across the entire skull and left facial region. Patient B did not experience pain relief from analgesics or more aggressive treatments (denosumab). In both patients, evaluation of trigeminal nerve divisions (V1, V2, and V3) with CT and magnetic resonance imaging (MRI) revealed nerve compression and displacement with more involvement of the left trigeminal branches relative to the right. First-time employment of diffusion MRI and tractography suggested reduced apparent fiber density within the cisternal segment of the trigeminal nerve, particularly for Patient B and in the left hemisphere. These cases highlight heterogeneous clinical presentation and neurobiological properties in craniofacial FD and also, the disconnect between peripheral pathology and pain severity. We hypothesize that a detailed phenotypic characterization of patients that incorporates an advanced imaging approach probing the trigeminal system may provide enhanced insights into the variable experiences with pain in craniofacial FD.

[1]  K. Digre,et al.  Mild traumatic brain injury affects the features of migraine , 2021, The Journal of Headache and Pain.

[2]  M. Collins,et al.  Denosumab for craniofacial fibrous dysplasia: duration of efficacy and post-treatment effects , 2021, Osteoporosis International.

[3]  E. Kraft,et al.  Pain Phenotypes in Rare Musculoskeletal and Neuromuscular Diseases , 2021, Neuroscience & Biobehavioral Reviews.

[4]  L. Kaban,et al.  Natural History and Progression of Craniofacial Fibrous Dysplasia: A Retrospective Evaluation of 114 Patients From Massachusetts General Hospital. , 2020, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[5]  Alexandra J. Golby,et al.  Creation of a novel trigeminal tractography atlas for automated trigeminal nerve identification , 2020, NeuroImage.

[6]  Alexandra J. Golby,et al.  Anatomical assessment of trigeminal nerve tractography using diffusion MRI: A comparison of acquisition b-values and single- and multi-fiber tracking strategies , 2020, NeuroImage: Clinical.

[7]  P. Dijkstra,et al.  Denosumab in Patients with Fibrous Dysplasia Previously Treated with Bisphosphonates. , 2019, The Journal of clinical endocrinology and metabolism.

[8]  A. Leithner,et al.  Pain in fibrous dysplasia: relationship with anatomical and clinical features , 2019, Acta orthopaedica.

[9]  S. Paul,et al.  Age‐Related Changes and Effects of Bisphosphonates on Bone Turnover and Disease Progression in Fibrous Dysplasia of Bone , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  T. Mom,et al.  Craniofacial fibrous dysplasia: A 10-case series. , 2017, European annals of otorhinolaryngology, head and neck diseases.

[11]  K. Cook,et al.  Development and Validation of a Daily Pain Catastrophizing Scale. , 2017, The journal of pain : official journal of the American Pain Society.

[12]  P. Dijkstra,et al.  Determinants of impaired quality of life in patients with fibrous dysplasia , 2017, Orphanet Journal of Rare Diseases.

[13]  Hyunsook Kim,et al.  Gsα Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and β-Catenin Pathways , 2017, Scientific Reports.

[14]  I. Chiodini,et al.  Prompt clinical and biochemical response to denosumab in a young adult patient with craniofacial fibrous dysplasia. , 2016, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

[15]  Steen Moeller,et al.  The Human Connectome Project's neuroimaging approach , 2016, Nature Neuroscience.

[16]  K. Kim Headache Attributed to Fibrous Dysplasia of the Ethmoid Bone Mimicking Menstrual Migraine Without Aura , 2016, The Journal of craniofacial surgery.

[17]  D. Haynes,et al.  Fibrous dysplasia of the temporal bone: A review of 66 cases , 2015, The Laryngoscope.

[18]  R. Chapurlat,et al.  Transient improvement of severe pain from fibrous dysplasia of bone with denosumab treatment. , 2014, Joint, bone, spine : revue du rhumatisme.

[19]  S. Wientroub,et al.  A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone. , 2014, The Journal of clinical endocrinology and metabolism.

[20]  M. Seibel,et al.  Rapid biochemical response to denosumab in fibrous dysplasia of bone: report of two cases , 2014, Osteoporosis International.

[21]  A. Molinolo,et al.  Effects of denosumab treatment and discontinuation on human growth plates. , 2014, The Journal of clinical endocrinology and metabolism.

[22]  J. Lee,et al.  Clinical guidelines for the management of craniofacial fibrous dysplasia , 2012, Orphanet Journal of Rare Diseases.

[23]  P. Mantyh,et al.  Pathophysiology and medical treatment of pain in fibrous dysplasia of bone , 2012, Orphanet Journal of Rare Diseases.

[24]  R. Edwards,et al.  Pain catastrophizing: a critical review , 2009, Expert review of neurotherapeutics.

[25]  Bin Liu,et al.  The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gsα gene: site‐specific patterns and recurrent histological hallmarks , 1999 .

[26]  C. Aring,et al.  A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.

[27]  T. Seifert The relationship of migraine and other headache disorders to concussion. , 2018, Handbook of clinical neurology.

[28]  Tournis Symeon,et al.  The use of bisphosphonates in women prior to or during pregnancy and lactation , 2011 .

[29]  M. Kelly,et al.  Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions , 2007, Osteoporosis International.

[30]  P. Trénor,et al.  [Fibrous dysplasia in McCune-Albright-syndrome]. , 2005, Revista espanola de medicina nuclear.

[31]  John H. Jopson,et al.  A REPORT OF TWO CASES , 1902 .